Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Battezzati, A.
Right arrow Articles by Luzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Battezzati, A.
Right arrow Articles by Luzi, L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:1690-1698, 2002
© 2002 by the American Diabetes Association, Inc.

Amino Acid Kinetics During the Anhepatic Phase of Liver Transplantation

Alberto Battezzati1,2, Andrea Caumo2, Annalisa Fattorini2, Lucia Piceni Sereni2, Jorgelina Coppa3, Raffaele Romito3, Mario Ammatuna3, Enrico Regalia3, Vincenzo Mazzaferro3, and Livio Luzi1,2

1 Università degli Studi di Milano, Milan, Italy
2 Department of Medicine, Istituto Scientifico H San Raffaele, Milan, Italy
3 Liver Transplantation Unit, Istituto Nazionale dei Tumori, Milan, Italy

Alanine and glutamine are interorgan nitrogen/carbon carriers for ureagenesis and gluconeogenesis, which are mainly but not necessarily only hepatic. The liver is central to alanine and glutamine metabolism, but most organs can produce and use them. We studied amino acid kinetics after liver removal to depict initial events of liver failure and to provide a model to study extrahepatic gluconeogenesis and nitrogen disposal in humans. We measured amino acid kinetics with [5,5,5-2H3]leucine and [3-13C]alanine or [1,2-13C2]glutamine tracers in 21 subjects during and after the anhepatic phase of liver transplantation: 12 were at 7 months posttransplantation, and 7 were healthy control subjects. Anhepatic leucine kinetics, including proteolysis, was unchanged. Alanine plasma and whole-body contents increased 3x and 2x, with a halved metabolic clearance and a doubled production, 2% greater than disposal. Free whole-body glutamine decreased 25% but increased 50% in plasma. Glutamine clearance was halved, and the production decreased by 25%, still 2% greater than disposal. Liver replacement decreased alanine and glutamine concentrations, leaving leucine unchanged. Liver removal caused doubled alanine fluxes, minor changes in glutamine, and no changes in leucine. The initial events after liver removal are an accumulation of three-carbon compounds, an acceleration of alanine turnover, and limited nitrogen storage in alanine and glutamine.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. G. Boelens, G. C. Melis, P. A. van Leeuwen, G. A. ten Have, and N. E. Deutz
Route of administration (enteral or parenteral) affects the contribution of L-glutamine to de novo L-arginine synthesis in mice: a stable-isotope study
Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E683 - E690.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Battezzati, A. Caumo, F. Martino, L. P. Sereni, J. Coppa, R. Romito, M. Ammatuna, E. Regalia, D. E. Matthews, V. Mazzaferro, et al.
Nonhepatic glucose production in humans
Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E129 - E135.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.